.png)
Blythe Thomson, MD
Sr. Vice President, Hematology & Oncology
Greg Hale, MD, FAAP
Vice President, Hematology & Oncology
Ann Woolfrey, MD
Vice President, Hematology & Oncology
.png)
Francis LeBlanc, MD, PhD
Medical Director, Hematology & Oncology
Philip Roehrs, MD
Medical Director, Hematology & Oncology
Jennifer Pullum, BS, RN
Sr. Executive Director, Clinical Trial Management
Madhavi Malladi, PhD
Sr. Associate Director, Clinical Trial Management
Brent Tharp, JD
Director, Business Development
Jack O'Brien, BS
Business Development Executive
Josh Vassallo, BS
Business Development Associate
Sarah Wasoski, BS
Business Development Executive
Stevie Wolf
Business Development Associate
Your Next Breakthrough Starts Here
HEMATOLOGY CRO
Through our proven full-service outsourcing model, Medpace consistently delivers high-quality results, showcasing profound expertise in managing Phase I-IV trials. Operating in 44 countries, we have earned a reputation for taking on some of the most complex and challenging cancer research studies.
- Led by a team of medical, operational, and regulatory experts experienced in hematology and oncology
- Integrated services and systems through out wholly-owned Central Laboratories, Bioanalytical Lab, Imaging Core Lab, ECG Core Lab, and Phase I Unit, in addition to our Clinical Trial Management System
- Preferred provider relationships with key sites, expediting site start-up, enhancing recruitment, and maximizing trial efficacy
- Experience in targeted, advanced, and radiation therapies
